2939results about How to "Significant positive effect" patented technology

A soft grip medical connector comprises a housing with an upstream end, a downstream end and a lumen extending through a central portion thereof. A flexible member comprises a valve portion integrally formed with a sleeve portion. The valve portion is positioned within a section of the housing and is configured to control a flow of fluid through the housing lumen. The sleeve is inverted to envelope at least a portion of the outer surface of the housing. In some embodiments the gripping portion is integrally formed with the valve portion. In some embodiments, the connector is also generally configured to create a positive pressure in a catheter lumen upon removal of a syringe or other medical device from the upstream end of the connector. Methods of making a medical fluid connector generally comprise forming a valve member with a sleeve extending there from, and assembling the valve, sleeve and housing.

A micromechanical structural element, having a very stable diaphragm, implemented in a pure front process and in a layer construction on a substrate. The layer construction includes at least one sacrificial layer and one diaphragm layer above the sacrificial layer, which is structured for laying bare the diaphragm and generating stabilizing elements on the diaphragm, at least one recess being generated for a stabilizing element of the diaphragm. The structure generated in the sacrificial layer is then at least superficially closed with at least one material layer being deposited above the structured sacrificial layer, this material layer forming at least a part of the diaphragm layer and being structured to generate at least one etch hole for etching the sacrificial layer, which is removed from the region under the etch hole, the diaphragm and the at least one stabilizing element being laid bare, a cavity being created under the diaphragm.

A method of processing financial data may include determining if a relationship exists between a particular item of said financial data and a quantifiable quality-related characteristic. It may further include generating data quantifying usage of the quality-related characteristic based on a particular item of financial data.

PCT No. PCT/EP96/01137 Sec. 371 Date Sep. 24, 1997 Sec. 102(e) Date Sep. 24, 1997 PCT Filed Mar. 15, 1996 PCT Pub. No. WO96/30558 PCT Pub. Date Oct. 3, 1996The invention concerns an aqueous corrosion-protective cleaning solution for tin-plated steel, in particular for tin-plated steel cans, the solution containing complex fluorides of the elements boron, titanium, zirconium, and hafnium; non-ionic surfactants; and corrosion inhibitors and having a pH within the range from 3 to 6. The invention also concerns an aqueous concentrate for preparing the solution by dilution with water and a method of cleaning tin-plated cans using the solution.

Methods and compositions are provided for protecting or enhancing a responsive cell, tissue, organ or body part function or viability in vivo, in situ or ex vivo in mammals, including human beings, by systemic or local administration of an erythropoietin receptor activity modulator, such as an recombinant tissue protective cytokine.

An electrical connector includes a connector housing (2) and a printed circuit board (3) with two sets of contact elements (7, 8). The first set of contact elements (7) is located on the front face of the printed circuit board (3) and protrudes into an opening in the plug connector housing (2). The second set of contact elements (8) is located on the rear face of the printed circuit board (3). The contact elements of the second set (8) are configured to form insulation-displacement contacts (8). The plug connector (1) also includes a cable manager (5) which has a continuous opening (13) and is configured on the front face (16) with guides (19) for cores or wires which are intended to make contact with the insulation-displacement contacts (8). The guides (19) in the region of the insulation-displacement contacts (8) are configured with recessed receiving elements or holders (20) for the insulation-displacement contacts (8), and the cable manager (5) can be latched to the plug connector housing (2).

An electromagnetic stimulation device which is comprised of a plurality of overlapping coils which are able to be independently energized in a predetermined sequence such that each coil will generate its own independent electromagnetic field and significantly increase the adjacent field. The coils are co-planar and are disposed in an ergonomic body wrap, which is properly marked to permit an unskilled patient to locate the body wrap, on a particular part of the body, of the patient so that the stimulation coils will maximize the electromagnetic stimulation on the selected nerves, muscles, and/or body tissues near the treated area. The device can be used to treat medical conditions including: muscular atrophy, neuropathic bladder and bowel, musculoskeletal pain, arthritis, as well as possible future applications in the prevention of deep vein thrombosis and weight reduction.

A pharmaceutical preparation suitable for use in the eye, which comprises: (i) a pharmaceutically acceptable carrier suitable for use in the eye; (ii) one or more ingredients selected from factors and agents that promote any one or more of survival, health, cell attachment and normal differentiation of ocular surface epithelial cells and optionally factors and agents to prevent squamous metaplasia; (iii) one or more agents capable of altering the fluid properties of a tear film including at least one agent capable of establishing and/or maintaining a stable tear film and optionally one or more agents selected from opthalmological lubricating agents, viscosity enhancing agents and agents capable of reducing tear film evaporation; the factors and agents in component (ii) and (iii) being synthetic or recombinant or licensed for pharmaceutical use.

A method and device for transmitting, sending and/or receiving information in conjunction with a vehicle. Information used for implementing vehicle-related remote monitoring being transmitted via a mobile radio network. In this connection, the communication takes place on the basis of a standardized protocol that is adapted to the conditions of the mobile radio network, which may be the WAP protocol.

This invention relates to compounds of the formula

wherein one of R⁵, R⁶ and R⁷ is

and X¹, X², Y¹ to Y⁴, R¹ to R¹³ and m and n are defined in the description, and to all enantiomers and pharmaceutically acceptable salts and/or esters thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPARδ and/or PPARα agonists.

The invention relates to a method, a device and a binding agent system for producing three-dimensional models.

The present invention relates to pest and disease preventing and controlling agent containing several kinds of microbes and its production process. The pest and disease preventing and controlling agent consists of several kinds of biocontrol microbes and beneficial microbes, nutritive liquid for the microbes to grow, plant source medicine and diatomite as adsorbent. It has high and lasting effect, less resistance, less environmental pollution, simple production process and stable quality. It is used in preventing and controlling pests and diseases in crop and city plant and in preventing and controlling roach, mosquito, fly and other pests.

In certain aspects, the present invention provides compositions and methods for treating fatty liver disease by administering an antagonist of an ActRIIB signaling pathway. Examples of such antagonists include ActRIIB polypeptides, anti-ActRIIB antibodies, anti-myostatin antibodies, anti-GDF3 antibodies and anti-activin A or B antibodies. A variety of hepatic and metabolic disorders may be improved by treating fatty liver disease.

The invention provides a data sharing method between electronic devices and the electronic devices. The method includes the steps that a client in a source device determines to-be-shared content selected by a user, generates a two-dimensional code according to connection information adopted by the source device and used for wireless connection with a target device, and displays the two-dimensional code; a client in the target device reads the two-dimensional code through a camera unit and obtains the connection information from the two-dimensional code; the client establishes wireless connection with the source device according to the connection information; after the successful establishment of the wireless connection, the client in the source device sends the to-be-shared content to the target device; and the client in the target device stores the received to-be-shared content in the target device. According to the technical scheme, a convenient and fast data sharing mode is provided for the electronic devices, particularly portable electronic devices.

A core glass and a fiber-optic light guide made from it are described. The core glass is in the alkali-zinc-silicate system and contains, in Mol % on an oxide basis: 54.5-65, SiO₂; 18.5-30, ZnO; 8-20, Σ alkali oxides; 0.5-3, La₂O₃; 2-5, ZrO₂; 0.02-5, HfO₂; 2.02-5, ΣZrO₂+HfO₂; 0.4-6, BaO; 0-6, SrO; 0-2, MgO; 0-2, CaO; 0.4-6, Σ alkaline earth oxides; 0.5-3, Li₂O, but no more Li₂O than 25% of the Σ alkali oxides; >58.5, Σ SiO₂+ZrO₂+HfO₂. A molar ratio of Na₂O/K₂O is from 1/1.1 to 1/0.3. A molar ratio of ZnO to BaO is greater than 3.5.

This application describes methods and compositions for detecting and treating HLTF-associated neoplasia. Differential methylation of the HLTF nucleotide sequences has been observed in HLTF-associated neoplasia such as colon neoplasia.

The pharmaceutical preparation for treating endometriosis contains at least 28, preferably 30, daily dose units, each of which contain dienogest, cyproterone acetate, or chlormadinone acetate at a daily dose that is at most twice that required to inhibit ovulation together with one or more pharmaceutical aids and/or carriers. The daily dose units are administered in a method of prophylaxis and/or therapy of endometriosis continuously during a time interval of at least 169 days or 25 weeks, preferably more than two years. The method effectively reduces endometriosis and associated pain, while undesirable side effects including bone density decrease are reduced or eliminated.

The invention relates to a method for testing the electricity of an ultrahigh-voltage transmission line based on electric field measurement, which comprises the following steps: 1, establishing a measurement point; 2, measuring an electric field; 3, establishing a transmission line power frequency inverse problem equivalent model; and 4, computing the voltage of the transmission line according to the electric field at the measurement point to obtain the actual voltage of each phase of transmission line, if the voltage of the transmission line is below 30 V, determining the transmission line is electrically neutral, otherwise, determining the transmission line is electrified. The invention also relates to a system for implementing the method for testing the electricity of the ultrahigh-voltage transmission line based on the electric field measurement, which consists of an electricity testing terminal and a data processing centre. The method and the system realize the non-contact electricity testing of the ultrahigh-voltage transmission line and ensure the safety of workers. Because the voltage level of the ultrahigh-voltage transmission line is high and a safe distance is long, the safe, effective and new method for testing the electricity of the ultrahigh-voltage transmission line is provided.

The invention provides a beverage substance cartridge, an identifying apparatus, a beverage producing equipment, a beverage producing system and a beverage producing method which could supply water automatically instead of manual work, identify information about beverage substance likewise such as variety and years of tea leaf, and furthermore, take different brewing methods targeting at different beverage substances (e.g. tea leaf) according to identified information in collaboration with pre-stored beverage brewing parameters to make sure every beverage substance could be brewed according to the perfect method, so the advantage of beverage substance will be given into full play. The beverage producing equipment which adopts the invention could yield brewing results accomplished by specialists and furthermore be widely used in offices and homes.

The present invention relates to a method for enhancing uniformity of metal oxide coatings formed by Atomic Layer Deposition (ALD) or ALD-type processes. Layers are formed using alternating pulses of metal halide and oxygen-containing precursors, preferably water, and purging when necessary. An introduction of modificator pulses following the pulses of the oxygen-containing precursor affects positively on layer uniformity, which commonly exhibits gradients, particularly in applications with closely arranged substrates. In particular, improvement in layer thickness uniformity is obtained. According to the invention, alcohols having one to three carbon atoms can be used as the modificator.